Generation and characterization of a human monoclonal antibody that neutralizes diverse HIV-1 isolates in vitro.

Generation and characterization of ixekizumab, a humanized monoclonal antibody that neutralizes interleukin-17A.

Generation and characterization of tabalumab, a human monoclonal antibody that neutralizes both soluble and membrane-bound B-cell activating factor.

A monoclonal antibody that neutralizes Epstein-Barr virus, human cytomegalovirus, human herpesvirus 6, and bacteriophage T4 DNA polymerases.

Characterization of a monoclonal antibody that selectively recognizes a subset of Entamoeba histolytica isolates.

A high-affinity native human antibody neutralizes human cytomegalovirus infection of diverse cell types.

Generation and Characterization of a New Monoclonal Antibody Against CXCL4.

Generation, characterization and preclinical studies of a human anti-L1CAM monoclonal antibody that cross-reacts with rodent L1CAM.

Human Monoclonal Antibody 81.39a Effectively Neutralizes Emerging Influenza A Viruses of Group 1 and 2 Hemagglutinins.

Generation and characterization of a protective mouse monoclonal antibody against human enterovirus 71.

A human monoclonal IgG that binds aβ assemblies and diverse amyloids exhibits anti-amyloid activities in vitro and in vivo.

Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type IIIMN strain.

Characterization of a monoclonal antibody specific for human active renin.

A Naturally Occurring Antibody Fragment Neutralizes Infectivity of Diverse Infectious Agents.

Characterization of a monoclonal antibody that specifically binds to choline phospholipids and its use in immunocytochemistry.

A human monoclonal antibody against the CD4-binding site of HIV1 gp120 exhibits potent, broadly neutralizing activity.

Generation and characterization of a neutralizing rat anti-rmTNF-alpha monoclonal antibody.

c Mice.

Generation and characterization of function-blocking anti-ectodysplasin A (EDA) monoclonal antibodies that induce ectodermal dysplasia.

c mice.

Generation and characterization of monoclonal antibody against Advanced Glycation End Products in chronic kidney disease.

A three monoclonal antibody combination potently neutralizes multiple botulinum neurotoxin serotype F subtypes.

Function characterization of a glyco-engineered anti-EGFR monoclonal antibody cetuximab in vitro.

Characterization of a Ca (II)-independent monoclonal antibody that lacks reactivity with Gla-domainless human factor VII.

Development of an antibody that neutralizes soluble IgE and eliminates IgE expressing B cells.

Suggest Documents

Generation and characterization of ixekizumab, a humanized monoclonal antibody that neutralizes interleukin-17A.

Generation and characterization of tabalumab, a human monoclonal antibody that neutralizes both soluble and membrane-bound B-cell activating factor.

A monoclonal antibody that neutralizes Epstein-Barr virus, human cytomegalovirus, human herpesvirus 6, and bacteriophage T4 DNA polymerases.

Characterization of a monoclonal antibody that selectively recognizes a subset of Entamoeba histolytica isolates.

A high-affinity native human antibody neutralizes human cytomegalovirus infection of diverse cell types.

Generation and Characterization of a New Monoclonal Antibody Against CXCL4.

Generation, characterization and preclinical studies of a human anti-L1CAM monoclonal antibody that cross-reacts with rodent L1CAM.

Human Monoclonal Antibody 81.39a Effectively Neutralizes Emerging Influenza A Viruses of Group 1 and 2 Hemagglutinins.

Generation and characterization of a protective mouse monoclonal antibody against human enterovirus 71.

A human monoclonal IgG that binds aβ assemblies and diverse amyloids exhibits anti-amyloid activities in vitro and in vivo.

Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type IIIMN strain.

Characterization of a monoclonal antibody specific for human active renin.

A Naturally Occurring Antibody Fragment Neutralizes Infectivity of Diverse Infectious Agents.

Characterization of a monoclonal antibody that specifically binds to choline phospholipids and its use in immunocytochemistry.

A human monoclonal antibody against the CD4-binding site of HIV1 gp120 exhibits potent, broadly neutralizing activity.

Generation and characterization of a neutralizing rat anti-rmTNF-alpha monoclonal antibody.

c Mice.

Generation and characterization of function-blocking anti-ectodysplasin A (EDA) monoclonal antibodies that induce ectodermal dysplasia.

c mice.

Generation and characterization of monoclonal antibody against Advanced Glycation End Products in chronic kidney disease.

A three monoclonal antibody combination potently neutralizes multiple botulinum neurotoxin serotype F subtypes.

Function characterization of a glyco-engineered anti-EGFR monoclonal antibody cetuximab in vitro.

Characterization of a Ca (II)-independent monoclonal antibody that lacks reactivity with Gla-domainless human factor VII.

Development of an antibody that neutralizes soluble IgE and eliminates IgE expressing B cells.

Generation and characterization of a human monoclonal antibody that neutralizes diverse HIV-1 isolates in vitro.

Recommend Documents

Follow Us